SuanFarma-Header SuanFarma-Header


Find Clinical Drug Development Pipelines & Deals | PipelineProspector


All Data

Filters Filter
filter Country
    filter News Type
      filter Company
        filter Product Type
          filter Deal Size

            Active Filter(s):

            Product Type


            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Lead Product(s): S011806

            Therapeutic Area: Dermatology Product Name: S011806

            Highest Development Status: IND Enabling Product Type: Small molecule

            Partner/Sponsor/Collaborator: RA Capital Management

            Deal Size: $60.0 million Upfront Cash: Undisclosed

            Deal Type: Series C Financing August 24, 2021


            Proceeds of the financing are expected to be used to support advancement of the Company’s preclinical IL-17 antagonist, S011806 into clinical development, advancement of preclinical α4ß7 and αVß1/αVß6 integrin programs, pipeline expansion and other general corporate purposes.